In a nutshell This study compared the effectiveness of three low-intensity chemotherapy combinations to treat patients with classical Hodgkin lymphoma (HL) following stem cell transplantation (SCT). There were no significant differences between the three chemotherapy types in terms of patients’ survival and relapse. Some background...
Read More
In a nutshell This article reviewed treatment options for patients with Hodgkin lymphoma (HL), aged 60 or older. Some background Approximately 20% of patients with HL are aged 60 or older. Treatment options for older patients with HL differ from patients under 60. This is because older patients are more often diagnosed with advanced HL...
Read More
In a nutshell This study compared CT and PET scans to understand which was more accurate at predicting biological treatment results in patients with relapsed or refractory Hodgkin lymphoma (HL). The results showed that PET scans were more sensitive than CT scans in these patients. Some background Biological therapy has improved treatment results...
Read More
In a nutshell This study examined the effectiveness and safety of immunotherapy before stem cell transplantation (SCT) in patients with Hodgkin lymphoma (HL). The authors concluded that this therapy increased the time before HL worsened and did not increase side effects. Some background Immunotherapy, including anti-PD-1 treatment such as...
Read More
In a nutshell This study examined how common depression and anxiety are amongst patients with Hodgkin lymphoma (HL) compared to the general population. The authors found that more medications for depression or anxiety are prescribed to patients with HL than to the general population. Some background Patients who develop or recover from cancer...
Read More
In a nutshell This study examined if the outcomes of stem cell transplants (SCT) have improved for young patients with relapsed or refractory Hodgkin lymphoma (HL) over time. The results showed that SCT has improved the survival rate and reduced the relapse rate of HL in young patients in recent years. Some background While initial treatment is...
Read More
In a nutshell This study examined the effectiveness and safety of the chemotherapy combination BV-DHAP for patients with relapsed or refractory Hodgkin lymphoma (HL). The authors found that BV-DHAP was an effective and safe treatment to progress patients to high-dose chemotherapy and stem cell transplant. Some background During treatment, some...
Read MoreIn a nutshell This study examined the long-term survival of patients who received stem cell transplants (SCT) and compared them to the general population. The authors found that patients who received SCTs had almost the same chance of survival as the general population and identified factors that alter this chance. Some background Treatments such...
Read MoreIn a nutshell This study examined the long-term survival of patients who received stem cell transplants (SCT) and compared them to the general population. The authors found that patients who received SCTs had almost the same chance of survival as the general population and identified factors that alter this chance. Some background Treatments such...
Read More
In a nutshell This study examined how often patients with Hodgkin lymphoma develop blood clots and what factors increase this risk. The results showed that a minority of patients develop blood clots and that there are several factors that increase the chance of blood clots developing. Some background Blood clots are more common in patients with...
Read More
In a nutshell This study looked at long-term outcomes of patients with early-stage Hodgkin lymphoma according to different treatments. It found that patients who received both radiation and chemotherapy had improved long-term survival compared to either treatment alone. Some background At present, over 90% of patients with classical Hodgkin lymphoma...
Read More
In a nutshell This study examined the effectiveness and safety of high-dose chemotherapy and stem cell transplants for children with lymphoma. The study showed that the combination treatment was very effective but that the dose may need to be adjusted for some patients. Some background Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL)...
Read More
